Therapeutic potential of neuregulin-1 in cardiovascular disease

Drug Discovery Today

Volumn 18, Issue 17-18, 2013, Pages 836-842

  Mendes Ferreira, Pedro ^a   De Keulenaer, Gilles W ^b   Leite Moreira, Adelino F ^a   Brás Silva, Carmen ^a,c  

^a University of Porto   (Portugal)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; S6 KINASE; TRASTUZUMAB;

AORTA STENOSIS; BREAST CARCINOMA; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CONGESTIVE CARDIOMYOPATHY; DIABETIC CARDIOMYOPATHY; ENDOCARDIAL CUSHION; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION SYSTEM; HEART PERFORMANCE; HUMAN; INOTROPISM; INTRACELLULAR SIGNALING; LUNG WEDGE PRESSURE; MESENCHYME CELL; METABOLIC STRESS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; REVIEW; SARCOPLASMIC RETICULUM; SURVIVAL; SYSTEMIC VASCULAR RESISTANCE;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; NEUREGULIN-1; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84883242344     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.01.010     Document Type: Review

References (62)

1. S. Britsch The neuregulin-I/ErbB signaling system in development and disease Adv. Anat. Embryol. Cell Biol. 190 2007 1 65
2. X. Luo Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination J. Biol. Chem. 286 2011 23967 23974
3. D.L. Falls Neuregulins: functions, forms, and signaling strategies Exp. Cell Res. 284 2003 14 30
4. K. Lemmens Role of neuregulin-1/ErbB2 signaling in endothelium- cardiomyocyte cross-talk J. Biol. Chem. 281 2006 19469 19477
5. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat. Rev. Mol. Cell Biol. 2 2001 127 137
6. D. Meyer, and C. Birchmeier Multiple essential functions of neuregulin in development Nature 378 1995 386 390
7. G.M. Cote Neuregulin-1 alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro Exp. Cell Res. 311 2005 135 146
8. D.L. Brutsaert Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity Physiol. Rev. 83 2003 59 115
9. M. Gassmann Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor Nature 378 1995 390 394
10. K.F. Lee Requirement for neuregulin receptor erbB2 in neural and cardiac development Nature 378 1995 394 398
11. S.L. Erickson ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice Development 124 1997 4999 5011
12. S. Rentschler Neuregulin-1 promotes formation of the murine cardiac conduction system Proc. Natl. Acad. Sci. U. S. A. 99 2002 10464 10469
13. H. Suk Kim Expression of ErbB receptors in ES cell-derived cardiomyocytes Biochem. Biophys. Res. Commun. 309 2003 241 246
14. W.Z. Zhu Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells Circ. Res. 107 2010 776 786
15. Y. Kuramochi Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling J. Biol. Chem. 279 2004 51141 51147
16. Y. Kuramochi Myocyte contractile activity modulates norepinephrine cytotoxicity and survival effects of neuregulin-1beta Am. J. Physiol. Cell Physiol. 286 2004 222 229
17. R. Fukazawa Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt J. Mol. Cell. Cardiol. 35 2003 1473 1479
18. S. Rohrbach Apoptosis-modulating interaction of the neuregulin/ErbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes J. Mol. Cell. Cardiol. 38 2005 485 493
19. K. Bersell Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury Cell 138 2009 257 270
20. R.R. Baliga NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK Am. J. Physiol. 277 1999 2026 2037
21. Y. Kuramochi Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes J. Mol. Cell. Cardiol. 41 2006 228 235
22. D.B. Sawyer Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1 beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity Circulation 105 2002 1551 1554
23. K. Lemmens Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase Circulation 109 2004 324 326
24. Y.Y. Zhao Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes Circ. Res. 84 1999 1380 1387
25. K. Okoshi Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion Circulation 110 2004 713 717
26. A. Brero Neuregulin-1 beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes Cardiovasc. Res. 88 2010 443 452
27. E. Iivanainen Intra- and extracellular signaling by endothelial neuregulin-1 Exp. Cell Res. 313 2007 2896 2909
28. K.S. Russell Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis Am. J. Physiol. 277 1999 2205 2211
29. L. Yen Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene 19 2000 3460 3469
30. N. Hedhli Endothelial derived neuregulin is an important mediator of ischemic induced angiogenesis and arteriogenesis Cardiovasc. Res. 93 2011 516 524
31. D. Panutsopulos Expression of heregulin in human coronary atherosclerotic lesions J. Vasc. Res. 42 2005 463 474
32. C.M. Clement Neuregulin-1 attenuates neointimal formation following vascular injury and inhibits the proliferation of vascular smooth muscle cells J. Vasc. Res. 44 2007 303 312
33. Y. Xu Neuregulin-1/ErbB signaling: a druggable target for treating heart failure Curr. Opin. Pharmacol. 9 2009 214 219
34. C. Ozcelik Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy Proc. Natl. Acad. Sci. U. S. A. 99 2002 8880 8885
35. S.A. Crone ErbB2 is essential in the prevention of dilated cardiomyopathy Nat. Med. 8 2002 459 465
36. H. Garcia-Rivello Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle Am. J. Physiol. Heart Circ. Physiol. 289 2005 1153 1160
37. S.J. Fang Neuregulin-1 preconditioning protects the heart against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism Chin. Med. J. (Engl.) 123 2010 3597 3604
38. K. Lemmens Cardioprotective effect of neuregulin-1 in myocardial ischemia-reperfusion injury relies on eNOS Circulation 124 2011 A9815
39. F.F. Liu Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure Am. J. Physiol. Heart Circ. Physiol. 289 2005 660 666
40. C. Vasti Doxorubicin and NRG-1/erbB4-deficiency affect gene expression profile: involving protein homeostasis in mouse ISRN Cardiol. 2012 2012 745185
41. K. Doggen Deficient cardiac neuregulin-ErbB signaling in type 2 diabetes, and beneficial effects of treatment with neuregulin-1 Circulation 120 2009 828
42. C. Gui Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy Cardiovasc. Pathol. 21 2012 414 420
43. K. Doggen Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure J. Mol. Cell. Cardiol. 46 2009 33 38
44. S. Rohrbach Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors Circulation 100 1999 407 412
45. A. Seidman Cardiac dysfunction in the trastuzumab clinical trials experience J. Clin. Oncol. 20 2002 1215 1221
46. G.W. De Keulenaer The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy Circ. Res. 106 2010 35 46
47. S. Rohrbach Neuregulin receptors erbB2 and erbB4 in failing human myocardium - depressed expression and attenuated activation Basic Res. Cardiol. 100 2005 240 249
48. B. Ky Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure Circulation 120 2009 310 317
49. G. Xu Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis Circ. Res. 105 2009 500 510
50. C. Anna Geisberg Circulating neuregulin-1beta levels vary according to the angiographic severity of coronary artery disease and ischemia Coron. Artery Dis. 22 2011 577 582
51. P.J. Perik Serum HER2 levels are increased in patients with chronic heart failure Eur. J. Heart Fail. 9 2007 173 177
52. M.G. Posch Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients Int. J. Cardiol. 145 2010 105 106
53. Y.F. Guo Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure Chin. Med. J. (Engl.) 125 2012 807 814
54. X. Liu Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy J. Am. Coll. Cardiol. 48 2006 1438 1447
55. X. Gu Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin Cardiovasc. Res. 88 2010 334 343
56. J. Xiao Therapeutic effects of neuregulin-1 gene transduction in rats with myocardial infarction Coron. Artery Dis. 23 2012 460 468
57. Y. Bian Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins Am. J. Physiol. Heart Circ. Physiol. 297 2009 1974 1983
58. B. Li Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats Cardiovasc. Diabetol. 10 2011 69
59. F. Timolati Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes J. Mol. Cell. Cardiol. 41 2006 845 854
60. R. Gao A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure J. Am. Coll. Cardiol. 55 2010 1907 1914
61. A. Jabbour Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses Eur. J. Heart Fail. 13 2011 83 92
62. N. Hedhli Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis Cardiovasc. Res. 93 2012 516 524